Grace Therapeutics, Inc. (GRCE)

NASDAQ: GRCE · Real-Time Price · USD

2.960

-0.010 (-0.34%)

At close: Jul 1, 2025, 4:00 PM

3.030

+0.070 (2.36%)

After-hours: Jul 1, 2025, 4:47 PM EDT

Grace Therapeutics Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Revenue	-	-	-	-	0.2	Upgrade
Cost of Revenue	-	-	-	-	0.08	Upgrade
Gross Profit	-	-	-	-	0.12	Upgrade
Selling, General & Admin	7.17	6.68	8.28	6.58	6.66	Upgrade
Research & Development	9.51	4.59	9.93	5.56	4.17	Upgrade
Operating Expenses	16.68	11.28	18.21	12.14	10.84	Upgrade
Operating Income	-16.68	-11.28	-18.21	-12.14	-10.72	Upgrade
Interest Expense	-	-	-	-	-0.26	Upgrade
Interest & Investment Income	0.71	0.91	0.25	0.08	0.11	Upgrade
Currency Exchange Gain (Loss)	-0.02	-0.02	-0.07	-0.3	-0.68	Upgrade
Other Non Operating Income (Expenses)	3.22	-2.73	0.01	5.34	-2.43	Upgrade
EBT Excluding Unusual Items	-12.77	-13.11	-18.02	-7.02	-13.98	Upgrade
Merger & Restructuring Charges	-	-1.49	-33.51	-3.2	-	Upgrade
Asset Writedown	-0	-0.09	-0.44	-0.25	-5.7	Upgrade
Pretax Income	-12.77	-14.69	-51.97	-10.47	-19.68	Upgrade
Income Tax Expense	-3.2	-1.83	-9.54	-0.65	-	Upgrade
Net Income	-9.57	-12.85	-42.43	-9.82	-19.68	Upgrade
Net Income to Common	-9.57	-12.85	-42.43	-9.82	-19.68	Upgrade
Shares Outstanding (Basic)	12	10	7	6	2	Upgrade
Shares Outstanding (Diluted)	12	10	7	6	2	Upgrade
Shares Change (YoY)	26.85%	28.16%	21.09%	148.46%	40.25%	Upgrade
EPS (Basic)	-0.79	-1.35	-5.71	-1.60	-7.96	Upgrade
EPS (Diluted)	-0.79	-1.35	-5.71	-1.60	-7.96	Upgrade
Free Cash Flow	-14.9	-12.36	-15.93	-17.23	-14.39	Upgrade
Free Cash Flow Per Share	-1.23	-1.30	-2.14	-2.81	-5.82	Upgrade
Gross Margin	-	-	-	-	61.22%	Upgrade
Operating Margin	-	-	-	-	-5467.35%	Upgrade
Profit Margin	-	-	-	-	-10039.80%	Upgrade
Free Cash Flow Margin	-	-	-	-	-7340.82%	Upgrade
EBITDA	-16.67	-11.27	-18.08	-11.22	-9.79	Upgrade
D&A For EBITDA	0.01	0.01	0.12	0.92	0.92	Upgrade
EBIT	-16.68	-11.28	-18.21	-12.14	-10.72	Upgrade

Updated Jun 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q